Specifically, it increased the infiltration of CD4+ and CD8+ T cells within breast tumors, facilitated the accumulation of CD8+ T cells at the tumor margins, decreased tumor size, and reduced incidence of lung metastases. The gene discussed is CD8A; the disease is neoplasm.